Quantum Biopharma Ltd. Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Apr 22, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed a 6-K on 4/22/25, confirming its foreign private issuer status.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on April 22, 2025. The company, incorporated in A6 with its principal executive offices in Toronto, Canada, is reporting as a foreign private issuer for the month of April 2025. Quantum Biopharma Ltd. is in the Pharmaceutical Preparations industry (SIC 2834).
Why It Matters
This filing indicates ongoing reporting requirements for Quantum Biopharma Ltd. as a foreign private issuer, providing transparency to investors about its regulatory status.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate increased risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- April 22, 2025 (date) — Filing date of the 6-K report
- Toronto, Ontario (location) — Location of principal executive offices
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that the issuer has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange on which its securities are traded, or that it has distributed or is required to distribute to its security holders.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
When did FSD Pharma Inc. change its name to Quantum Biopharma Ltd.?
The date of the name change from FSD Pharma Inc. to Quantum Biopharma Ltd. was March 27, 2019.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
Where are Quantum Biopharma Ltd.'s principal executive offices located?
Quantum Biopharma Ltd.'s principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 22, 2025 regarding Quantum Biopharma Ltd. (QNTM).